Gide, alongside the US firm Faegre Baker Daniels, advises the US group Zimmer Biomet, a global leader in musculoskeletal healthcare, in the context of the acquisition of Medtech, a leading French listed medical technology company. Zimmer Biomet has acquired 58.77% of the share capital of Medtech, from Mr. Bertin Nahum, Newfund and certain other selling stockholders in a private transaction, as well as all outstanding convertible bonds and warrants previously issued by Medtech to Ally Bridge Group.
In accordance with French law, Zimmer Biomet will launch, as soon as possible, via one of its wholly-owned subsidiaries, an all-cash simplified tender offer to acquire the remaining outstanding shares of Medtech.
Legal counsel to Zimmer Biomet:
France | Gide : Didier G. Martin and Antoine Tézenas du Montcel (partners), Régis Henry, Maud Harreau and Thomas Jaegle on the M&A aspects, Foulques de Rostolan (partner) and Caroline Merle on the employment aspects, Jean-Hyacinthe de Mitry and Océane Millon de La Verteville on the IP aspects
USA: Faegre Baker Daniels
Legal counsel to Medtech: Dechert